319 related articles for article (PubMed ID: 27910016)
1. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
2. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
3. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
4. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
5. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.
Dewald GW
Int J Hematol; 2002 Aug; 76 Suppl 2():65-74. PubMed ID: 12430903
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization panel for monitoring of minimal residual disease in patients with double minute chromosomes.
Jeon Y; Kim SY; Kim M; Park HK; Lee SH; See CJ; Kwon J; Lee DS
Blood Cells Mol Dis; 2014 Apr; 52(4):208-13. PubMed ID: 24211232
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases.
Ashok V; Ranganathan R; Chander S; Damodar S; Bhat S; S NK; A SK; Jadav SS; Rajashekaraiah M; T S S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3457-3464. PubMed ID: 29286619
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization: molecular probes for diagnosis of pediatric neoplastic diseases.
Raimondi SC
Cancer Invest; 2000; 18(2):135-47. PubMed ID: 10705876
[TBL] [Abstract][Full Text] [Related]
11. Detection of numerical aberrations in hematologic neoplasias by fluorescence in situ hybridization.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Balsamo R; Piva N; Castoldi G
Haematologica; 1997; 82(1):85-90. PubMed ID: 9107092
[TBL] [Abstract][Full Text] [Related]
12. Quick-FISH: a rapid fluorescence in situ hybridization technique for molecular cytogenetic analysis.
Banerjee SK; Weston AP; Persons DL; Campbell DR
Biotechniques; 1998 May; 24(5):826-30. PubMed ID: 9591133
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic applications in analysis of the cancer genome.
Rao PH; Nandula SV; Murty VV
Methods Mol Biol; 2007; 383():165-85. PubMed ID: 18217685
[TBL] [Abstract][Full Text] [Related]
14. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis.
Knight SJ; Flint J
J Med Genet; 2000 Jun; 37(6):401-9. PubMed ID: 10851249
[TBL] [Abstract][Full Text] [Related]
15. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
16. An approach for quantitative assessment of fluorescence in situ hybridization (FISH) signals for applied human molecular cytogenetics.
Iourov IY; Soloviev IV; Vorsanova SG; Monakhov VV; Yurov YB
J Histochem Cytochem; 2005 Mar; 53(3):401-8. PubMed ID: 15750029
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization: uses and limitations.
Gozzetti A; Le Beau MM
Semin Hematol; 2000 Oct; 37(4):320-33. PubMed ID: 11071355
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Fluorescence In Situ Hybridization (QFISH).
Iourov IY
Methods Mol Biol; 2017; 1541():143-149. PubMed ID: 27910021
[TBL] [Abstract][Full Text] [Related]
19. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
Michalová K
Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
